Physician profile
Michael Clark
NPI 1114988540
$1,738.25
in general payments reported to CMS, 2019-2025
17 companies · $15.46 in 2025
The $15.46 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $11.84 · 2022: $1,319 · 2023: $212 · 2024: $179 · 2025: $15.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $313 · Education: $94.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $312.94 |
| Education | $94.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Momentis Surgical INC. | $1,254.00 | 2022 | |
| Astellas Pharma US INC | $152.48 | 2023-2024 | Veozah |
| Hologic Sales and Service, LLC | $54.11 | 2022-2023 | Novasure, Myosure Tissue Removal Device, Coolseal Generator |
| Shield Therapeutics INC | $35.66 | 2023 | Accrufer |
| Sage Therapeutics, LLC | $26.87 | 2024 | |
| Minerva Surgical, INC | $26.25 | 2022-2024 | |
| Channel Medsystems, INC. | $24.01 | 2022 | |
| Medical Device Business Services, INC. | $23.70 | 2024 | Lcp |
| Optumhealth Care Solutions, LLC | $21.26 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Aspira Women'S Health INC | $17.87 | 2024 | Ova1 |
| Organon LLC | $17.02 | 2023 | Nexplanon |
| Smith+Nephew, INC. | $16.50 | 2024 | Stravix |
| Bayer Healthcare Pharmaceuticals INC. | $15.46 | 2025 | |
| Lilly USA, LLC | $14.55 | 2024 | Zepbound |
| Novo Nordisk INC | $13.53 | 2024 | Wegovy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $13.14 | 2022 | |
| Baxter Healthcare | $11.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.